HomeNewsBusinessGlenmark signs cancer drug licensing deal with China's Hengrui for $18 million upfront with $1.1 billion in milestone payments
Trending Topics
Business Top Story
Business
Business
Business 2
Business Story
Business News
business 1
business stock market
market live blog
business stock market live
fin festival

Glenmark signs cancer drug licensing deal with China's Hengrui for $18 million upfront with $1.1 billion in milestone payments

testuser testuser
September 24, 2025 / 17:54 IST
Story continues below Advertisement
Remove Ad
20250924174611_20250315034541_sensex_stocks_nifty.jpg
20250924174611_20250315034541_sensex_stocks_nifty.jpg

Glenmark signs cancer drug licensing deal with China's Hengrui for $18 million upfront with $1.1 billion in milestone payments

testuser testuser
first published: Sep 24, 2025 05:54 pm
Follow Us On: Facebook twitter instagram linkedin telegram youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.